Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
CVS is under pressure and considering a breakup. Here's why that could be risky.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health insurer Aetna and the major pharmacy benefits manager Caremark. That could translate to more lost profits for a health-care giant that has slashed its full-year 2024 earnings guidance for three consecutive quarters.
Here’s what CVS’s potential breakup could mean for you
Now, after the Woonsocket, R.I.-based health care giant had to again reduce its profit outlook and with its stock taking a pummeling on Wall Street, CVS is reportedly considering breaking itself into two smaller companies to keep its critics at bay.
Why a potential CVS breakup matters
A CVS breakup — which reportedly is on the table — would be pretty hard to actually do and could come with a lot of downsides, and most people seem skeptical it'll happen. But the fact that it's being discussed at all is notable in an era where vertical integration is all the rage.
CVS Considers Breakup
CVS Health (NYSE:CVS) finds its shares are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy reimbursement pressure, among other issues.
Fierce Healthcare
20h
Chutes & Ladders—Walgreens snags former Optum and CVS exec; Phoenix Children's bolsters 4 divisions
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to ...
13h
on MSN
What went wrong at CVS?
Pharmacy chains are in crisis ...
3d
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
From a valuation perspective, the stock is inexpensive, trading at a forward price-to-earnings (P/E) of about 8.4 times based ...
Crain's Chicago Business
1d
Walgreens names new chief commercial officer with health care, pharmacy background
Jason Stenta brings Optum and CVS Health experience to Walgreens as it struggles with the direction of an ill-fated health ...
Modern Healthcare
1d
Walgreens taps former Optum executive for chief commercial role
Jason Stenta will oversee commercial growth strategy at Walgreens and help develop partnerships with payers, providers and ...
Courthouse News Service
5d
CVS, Walgreens announce opioid settlements totaling $10B
The deals call for most of the funds from Woonsocket, Rhode Island-based
CVS
and Deerfield, Illinois-based
Walgreens
to be used to fight the opioid crisis through such efforts as expanding ...
5d
Why CVS Health Won’t Break Off Aetna From Its Medical Providers
Talk that CVS Health may break up its businesses would mean unraveling synergies already making the company a lot of money.
5d
Walgreens: No Catalysts To Drive A Turnaround
Walgreens has missed on margin expectations for multiple quarters now. Check out why I'm bearish on WBA stock.
7d
CVS is weighing a breakup. What does it mean for the big healthcare business?
With CVS ( CVS) reportedly weighing a breakup of its vertical businesses, the healthcare industry could be marching toward ...
1d
Walgreens names new COO, Jason Stenta
Walgreens Boots Alliance has named Jason Stenta SVP and chief commercial officer. Stenta will lead the company’s commercial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback